NovoCure Limited (NVCR) Total assets 2017–2026
NovoCure Limited (NVCR) total assets at each fiscal year-end, per SEC filings.
$804.3MFY2026 · since FY2017: $282.1M → $804.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $804.3M | -35.2% |
| FY2025 | $1.2B | +8.3% |
| FY2024 | $1.1B | -3.8% |
| FY2023 | $1.2B | +4.6% |
| FY2022 | $1.1B | +8.3% |
| FY2021 | $1.1B | +119.4% |
| FY2020 | $479.4M | +41.1% |
| FY2019 | $339.8M | +28.1% |
| FY2018 | $265.3M | -5.9% |
| FY2017 | $282.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NVCR financial trends
NVCR RevenueNVCR Net incomeNVCR Net marginNVCR Gross profitNVCR Gross marginNVCR Operating incomeNVCR Operating marginNVCR Operating cash flowNVCR Free cash flowNVCR Capital expendituresNVCR Return on equityNVCR Stock buybacksNVCR Dividends paidNVCR Total liabilitiesNVCR Shareholders’ equityNVCR overview →